Biotech Investors & VC Firms in China
202 firms in this list, with a median first check of $1.1M. 30 of them lead rounds. Generated from verified public data and updated continuously.
MPCi (formerly Matrix Partners China)
SingaporeSeed–Growth
11 people
Shanghai Creation Investment
ShanghaiLate Stage
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Hangzhou Industrial Investment Group
Hangzhou
Legend Star
北京Pre-Seed–Series A$425K – $112M
Sangel Capital
ShenzhenSeed–Late Stage
Hony Capital Ltd.
Hong KongGrowth–Late Stage$6M
6 people
Danen Capital
ShenzhenSeed–Growth
2 people
Volcanics Venture
ShanghaiSeed–Series B
8 people
TriWise Capital
ShenzhenPre-Seed–Late Stage
1 person
Gaorong Capital
BeijingSeed–Series B
5 people
Panda Capital
Pre-Seed–Late Stage
1 person
Zhongguancun Development Group
BeijingPre-Seed–Growth
CCV Capital
BeijingSeed–Series B
1 person
Haibang Capital
HangzhouPre-Seed–Late Stage
1 person
Lotus Lake Ventures
BeijingSeed–Series A
7 people
Fosun Pharma
Shanghai
Hefei High-tech VC
HefeiSeed–Series C
BioTrack Capital
Grand CaymanSeed–Late Stage
6 people
Dalton Venture
ShanghaiSeed–Series B
CDF-Capital
ShenzhenSeed–Late Stage
Comway Capital Ltd.
ShanghaiSeed–Series B
Shiyu Capital
HainanSeed–Late Stage
Zhejiang Paradise
HangzhouSeed
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.












